ASTRA Therapeutics
PrivateLast Round
Seed
Jul 24, 2025
Est. Valuation
$27.49M
Total Funding Raised
$9.53M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ASTRA Therapeutics operates in Healthcare & Life Sciences and is based in Villigen. Its latest recorded funding round was a Seed round in July 2025.
ASTRA Therapeutics is a biotechnology company that designs and develops novel parasiticides targeting eukaryotic pathogens in the animal health sector.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ASTRA Therapeutics Comparables
Compare ASTRA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Animol Discovery | 81% | |
| Bontia Bio | 78% | |
| Peptidus Biotech | 77% |
For institutional investors. Book with your work email.
ASTRA Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ASTRA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Seed |
| Digitalis Ventures | Seed |
| MIG AG | Seed |
| Borealis Ventures | Seed |
| Venture Kick | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 94% MoM.
- Apr 7, 2026
Monthly visitors grew 244% MoM.
For institutional investors. Book with your work email.
ASTRA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ASTRA Therapeutics's valuation, stock price, and market status.
Is ASTRA Therapeutics a public or private company?
ASTRA Therapeutics is a private company.
What is the current stock price of ASTRA Therapeutics?
ASTRA Therapeutics is a private company, so its shares have no public market price. Caplight tracks ASTRA Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ASTRA Therapeutics worth (valuation)?
ASTRA Therapeutics's valuation is estimated at $27.5M based on funding round data.
Can I buy ASTRA Therapeutics stock?
ASTRA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ASTRA Therapeutics's last funding round?
ASTRA Therapeutics's most recent funding round was Seed on July 24, 2025.
Who are the main investors in ASTRA Therapeutics?
Key investors in ASTRA Therapeutics include Digitalis Ventures, MIG AG.
Will ASTRA Therapeutics IPO soon?
No public IPO plans have been announced for ASTRA Therapeutics.
How can I track ASTRA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ASTRA Therapeutics's shares on secondary markets.